{"id":"https://openalex.org/W2000074754","doi":"https://doi.org/10.1111/j.1463-1326.2007.00765.x","title":"Incretin\u2010based treatment of type 2 diabetes: glucagon\u2010like peptide\u20101 receptor agonists and dipeptidyl peptidase\u20104 inhibitors*","display_name":"Incretin\u2010based treatment of type 2 diabetes: glucagon\u2010like peptide\u20101 receptor agonists and dipeptidyl peptidase\u20104 inhibitors*","alternate_titles":[],"publication_year":2007,"publication_date":"2007-09-01","ids":{"openalex":"https://openalex.org/W2000074754","doi":"https://doi.org/10.1111/j.1463-1326.2007.00765.x","mag":"2000074754","pmid":"https://pubmed.ncbi.nlm.nih.gov/17877544"},"language":"en","primary_location":{"id":"doi:10.1111/j.1463-1326.2007.00765.x","doi":"https://doi.org/10.1111/j.1463-1326.2007.00765.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2007.00765.x","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000074754"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054335526","display_name":"Carolyn Fiona Deacon","orcid":"https://orcid.org/0000-0003-2611-5642","observed_orcids":["https://orcid.org/0000-0003-2611-5642"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]}],"countries":["DK"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Carolyn F. Deacon","raw_affiliation_strings":["Department of Biomedical Sciences, Panum Institute, University of Copenhagen, Copenhagen, Denmark. deacon@mfi.ku.dk","Department of Biomedical Sciences, Panum Institute; University of Copenhagen; Copenhagen Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Sciences, Panum Institute, University of Copenhagen, Copenhagen, Denmark. deacon@mfi.ku.dk","institution_ids":["https://openalex.org/I124055696"]},{"raw_affiliation_string":"Department of Biomedical Sciences, Panum Institute; University of Copenhagen; Copenhagen Denmark","institution_ids":["https://openalex.org/I124055696"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5054335526"],"corresponding_institution_ids":["https://openalex.org/I124055696"],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":null,"fwci":0.7652,"has_fulltext":false,"cited_by_count":69,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.61579755,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"9","issue":"s1","first_page":"23","last_page":"31"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8500000238418579},{"id":"https://openalex.org/keywords/incretin-based-therapy","display_name":"incretin-based therapy","score":0.8500000238418579},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.968999981880188},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9819999933242798},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.875},{"id":"https://openalex.org/keywords/glucose-dependent-insulinotropic-polypeptide","display_name":"glucose-dependent insulinotropic polypeptide","score":0.9549999833106995},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.765999972820282},{"id":"https://openalex.org/keywords/beta-cell-mass","display_name":"beta-cell mass","score":0.7730000019073486},{"id":"https://openalex.org/keywords/glucagon-secretion","display_name":"glucagon secretion","score":0.7099999785423279},{"id":"https://openalex.org/keywords/gastric-emptying","display_name":"gastric emptying","score":0.871999979019165},{"id":"https://openalex.org/keywords/satiety","display_name":"satiety","score":0.9430000185966492},{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.8600000143051147},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":1.0},{"id":"https://openalex.org/keywords/sitagliptin","display_name":"sitagliptin","score":1.0},{"id":"https://openalex.org/keywords/vildagliptin","display_name":"vildagliptin","score":0.9829999804496765},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.996999979019165}],"concepts":[{"id":"https://openalex.org/C2776453732","wikidata":"https://www.wikidata.org/wiki/Q421042","display_name":"Vildagliptin","level":4,"score":0.8954972624778748},{"id":"https://openalex.org/C2778881409","wikidata":"https://www.wikidata.org/wiki/Q1420402","display_name":"Incretin","level":4,"score":0.8914629220962524},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.8351176381111145},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7459662556648254},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.739294707775116},{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.7094109058380127},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.6670527458190918},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.6307766437530518},{"id":"https://openalex.org/C3020479747","wikidata":"https://www.wikidata.org/wiki/Q1029907","display_name":"Gastric emptying","level":3,"score":0.5482870936393738},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5238221287727356},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4915402829647064},{"id":"https://openalex.org/C2910260750","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin Phosphate","level":5,"score":0.48219171166419983},{"id":"https://openalex.org/C2781469919","wikidata":"https://www.wikidata.org/wiki/Q5279728","display_name":"Dipeptidyl peptidase","level":3,"score":0.467746764421463},{"id":"https://openalex.org/C2776129832","wikidata":"https://www.wikidata.org/wiki/Q22677256","display_name":"Gastric inhibitory polypeptide","level":4,"score":0.4647737145423889},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.4481040835380554},{"id":"https://openalex.org/C2778563252","wikidata":"https://www.wikidata.org/wiki/Q170617","display_name":"Glucagon","level":3,"score":0.4074093699455261},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.3766067922115326},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.30940282344818115},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08237236738204956},{"id":"https://openalex.org/C2779422922","wikidata":"https://www.wikidata.org/wiki/Q1029907","display_name":"Stomach","level":2,"score":0.06006491184234619},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000067757","descriptor_name":"Glucagon-Like Peptide-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000078790","descriptor_name":"Insulin Secretion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D050417","descriptor_name":"Insulin-Secreting Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D054795","descriptor_name":"Incretins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1463-1326.2007.00765.x","doi":"https://doi.org/10.1111/j.1463-1326.2007.00765.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2007.00765.x","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:17877544","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17877544","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/5833b950-ab49-11dd-b5e9-000ea68e967b","doi":null,"is_oa":false,"landing_page_url":"https://researchprofiles.ku.dk/da/publications/5833b950-ab49-11dd-b5e9-000ea68e967b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401983","display_name":"Research at the University of Copenhagen (University of Copenhagen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I124055696","host_organization_name":"University of Copenhagen","host_organization_lineage":["https://openalex.org/I124055696"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Deacon, C F 2007, 'Incretin-based treatment of type 2 diabetes: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors.', Diabetes, Obesity and Metabolism, vol. 9 Suppl 1, pp. 23-31. https://doi.org/10.1111/j.1463-1326.2007.00765.x","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W1968676703","https://openalex.org/W1973489602","https://openalex.org/W1977619586","https://openalex.org/W1979916078","https://openalex.org/W1984740259","https://openalex.org/W1986085856","https://openalex.org/W1989976483","https://openalex.org/W1992966015","https://openalex.org/W1993287695","https://openalex.org/W1994743271","https://openalex.org/W1996407482","https://openalex.org/W2004977380","https://openalex.org/W2011499650","https://openalex.org/W2024917991","https://openalex.org/W2028849170","https://openalex.org/W2032322539","https://openalex.org/W2042529296","https://openalex.org/W2051462052","https://openalex.org/W2054564814","https://openalex.org/W2063014888","https://openalex.org/W2067710447","https://openalex.org/W2071648045","https://openalex.org/W2074511950","https://openalex.org/W2082070432","https://openalex.org/W2083473802","https://openalex.org/W2085862152","https://openalex.org/W2087707716","https://openalex.org/W2093738306","https://openalex.org/W2103525547","https://openalex.org/W2104938107","https://openalex.org/W2107298640","https://openalex.org/W2108771199","https://openalex.org/W2109157463","https://openalex.org/W2140978079","https://openalex.org/W2143014102","https://openalex.org/W2148182710","https://openalex.org/W2162934281","https://openalex.org/W2164961795","https://openalex.org/W2411384485","https://openalex.org/W4234825176"],"related_works":["https://openalex.org/W2019091650","https://openalex.org/W1980527181","https://openalex.org/W2066861619","https://openalex.org/W2064437324","https://openalex.org/W7216934368","https://openalex.org/W1902646265","https://openalex.org/W2154474547","https://openalex.org/W2092533097","https://openalex.org/W2538680713"],"abstract_inverted_index":{"Incretins":[0,83],"are":[1,84],"gut":[2],"peptides":[3],"that":[4,117],"potentiate":[5],"nutrient-stimulated":[6],"insulin":[7,28],"secretion":[8,29],"following":[9],"meal":[10],"ingestion.":[11],"Activities":[12],"of":[13,27,67,100,108,122,132],"the":[14,68,106],"dominant":[15],"incretins,":[16],"glucagon-like":[17],"peptide-1":[18],"(GLP-1)":[19],"and":[20,47,60,64,112,114,128],"glucose-dependent":[21,25],"insulinotropic":[22],"peptide,":[23],"include":[24],"stimulation":[26],"and,":[30],"in":[31,35,74,80,142,146],"preclinical":[32],"models,":[33],"improvement":[34],"islet":[36],"beta-cell":[37],"mass.":[38],"GLP-1":[39,62,101],"additionally":[40],"reduces":[41],"glucagon":[42],"secretion,":[43],"inhibits":[44],"gastric":[45],"emptying":[46],"promotes":[48],"satiety.":[49],"Patients":[50],"with":[51,148],"type":[52],"2":[53],"diabetes":[54],"mellitus":[55],"(T2DM)":[56],"exhibit":[57],"reduced":[58],"total":[59],"intact":[61,124],"levels,":[63],"exogenous":[65],"administration":[66],"hormone":[69],"via":[70],"continuous":[71],"infusion":[72],"results":[73],"glucose":[75],"profiles":[76],"similar":[77],"to":[78,93,105,119,139],"those":[79],"non-diabetic":[81],"subjects.":[82],"rapidly":[85],"degraded":[86],"by":[87],"dipeptidyl":[88],"peptidase-4":[89],"(DPP-4).":[90],"Thus,":[91],"strategies":[92],"enhance":[94],"incretin":[95],"activity":[96],"have":[97,136],"included":[98],"development":[99],"receptor":[102],"agonists":[103],"resistant":[104],"action":[107],"DPP-4":[109,115],"(e.g.":[110,126],"exenatide":[111],"liraglutide)":[113],"inhibitors":[116],"act":[118],"increase":[120],"concentrations":[121],"endogenous":[123],"incretins":[125],"sitagliptin":[127],"vildagliptin).":[129],"Clinical":[130],"trials":[131],"these":[133],"incretin-based":[134],"therapies":[135],"shown":[137],"them":[138],"be":[140],"effective":[141],"improving":[143],"glycaemic":[144],"control":[145],"patients":[147],"T2DM.":[149]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000074754","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
